If you’re presented with an affidavit by a US Food and Drug Administration investigator during a facility inspection, don’t sign it. In fact, don’t even listen to it being read aloud.
That’s advice from Jessica Ringel, a partner in the Washington, DC, office of law firm King & Spalding. She says device makers can land in hot water with the agency...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?